Skip to main content

Table 1 Clinical characteristics of the 142 CHC patients in this study

From: LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients

  CHC patients with serum and plasma specimens (n = 97) CHC patients treated with IFN and achieved RVR (n = 45)
Age (year) 52.30 ± 8.20 52.64 ± 7.49
Gender (male/female) 55/42 30/15
TBIL (μmol/L) 16.90 ± 7.40 /
DBIL (μmol/L) 7.47 ± 3.14 /
ALP (U/L) 88.41 ± 31.01 /
GGT (U/L) 79.79 ± 91.21 /
ALT (U/L) 57.88 ± 50.87 119.71 ± 110.95
AST (U/L) 45.50 ± 32.49 87.70 ± 82.70
PLT (×109/L) 189.07 ± 66.50 166.60 ± 83.20
FibroScan 9.44 ± 10.22 15.16 ± 7.63
MAL/DSA Serum: 10.01 ± 1.94 9.29 ± 2.39
Plasma: 10.35 ± 2.30
AOL/DSA Serum: 3.02 ± 3.43 6.34 ± 7.33
Plasma: 3.57 ± 4.78